A detailed history of Spider Rock Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 294,518 shares of ABBV stock, worth $52.1 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
294,518
Previous 246,564 19.45%
Holding current value
$52.1 Million
Previous $42.3 Million 37.53%
% of portfolio
0.94%
Previous 0.86%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$163.84 - $199.33 $7.86 Million - $9.56 Million
47,954 Added 19.45%
294,518 $58.2 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $446,104 - $520,950
-2,882 Reduced 1.16%
246,564 $42.3 Million
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $39.9 Million - $45.4 Million
249,446 New
249,446 $45.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Spider Rock Advisors, LLC Portfolio

Follow Spider Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.